ログイン

SUMMATIVE EXAM PART 1

SUMMATIVE EXAM PART 1
60問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    What is the lowest level of hormone for which most current serum hCG tests can give a positive result? A. 25 mIU/mL B. 50 mIU/mL C. 100 mIU/mL D. 200 mIU/mL

    A. 25 mIU/mL

  • 2

    In the card pregnancy test, if the test band appears very faint, it is recommended that it is: A. Reported as positive B. Reported as negative C. Test is considered invalid D. New sample collected 48 hours later and tested

    D. New sample collected 48 hours later and tested

  • 3

    Direct examination of the treponemes: A. Light microscopy B. Darkfield microscopy C. VDRL testing D. RPR testing

    B. Darkfield microscopy

  • 4

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? A. Antibodies against syphilis are undetectable B. Detected 1 to 3 weeks after appearance of the primary chancre C. Detected in 50% of cases before the primary chancre disappears D. Detected within 2 weeks after infection

    B. Detected 1 to 3 weeks after appearance of the primary chancre

  • 5

    What substance is detected by the rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests for syphilis? A. Cardiolipin B. Anticardiolipin antibody C. Anti-T. pallidum antibody D. Treponema pallidum

    B. Anticardiolipin antibody

  • 6

    What type of antigen is used in the RPR card test? A. Live treponemal organisms B. Killed suspension of treponemal organisms C. Cardiolipin D. Tanned sheep cells

    C. Cardiolipin

  • 7

    Speed and time of rotation for serum VDRL test: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    C. 180 rpm for 4 minutes

  • 8

    Speed and time of rotation for CSF VDRL test: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    D. 180 rpm for 8 minutes

  • 9

    Speed and time of rotation for RPR: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    B. 100 rpm for 8 minutes

  • 10

    In the RPR test, what is the gauge of the needle for antigen delivery? A. 16 B. 18 C. 20 D. 21

    C. 20

  • 11

    A widely used HEMAGGLUTINATION test for detecting antibody to Treponema pallidum is: A. MHA-TP test B. FTA-ABS test C. VDRL test D. TPI test

    A. MHA-TP test

  • 12

    . Which test is recommended for testing cerebrospinal fluid for detection of neurosyphilis? A. RPR B. VDRL C. FTA-ABS D. Enzyme immunoassay

    B. VDRL

  • 13

    Which specimen is the sample of choice to evaluate latent or tertiary syphilis? A. Serum sample B. Chancre fluid C. CSF D. Joint fluid

    C. CSF

  • 14

    Which test is most likely to be positive in the tertiary stage of syphilis? A. FTA-ABS B. RPR C. VDRL D. Reagin screen test (RST)

    A. FTA-ABS

  • 15

    A biological false-positive reaction is least likely with which test for syphilis? A. VDRL B. FTA-ABS C. RPR D. All are equally likely to detect a false-positive result

    B. FTA-ABS

  • 16

    Which of the following is the most sensitive test to detect congenital syphilis? A. VDRL B. RPR C. Microhemagglutination test for T. pallidum (MHA-TP) D. Polymerase chain reaction (PCR)

    D. Polymerase chain reaction (PCR)

  • 17

    Which control shows the correct result for a valid ASO test? A. SLO control, no hemolysis B. Red cell control, no hemolysis C. Positive control, hemolysis in all tubes D. Hemolysis in both SLO and red cell control

    B. Red cell control, no hemolysis

  • 18

    . Interpret the following ASO results: § Tube Nos. 1–4 (Todd unit 125): no hemolysis § Tube No. 5 (Todd unit 166): hemolysis A. Positive Todd unit 125 B. Positive Todd unit 166 C. No antistreptolysin O present D. Impossible to interpret

    A. Positive Todd unit 125

  • 19

    A single ASO titer is considered to be moderately elevated if the titer is at least _____ Todd units in an adult. A. 200 Todd units B. 240 Todd units C. 320 Todd units D. 340 Todd units

    B. 240 Todd units

  • 20

    A single ASO titer is considered to be moderately elevated if the titer is at least _____ Todd units in a child. A. 200 Todd units B. 240 Todd units C. 320 Todd units D. 340 Todd units

    C. 320 Todd units

  • 21

    What is the endpoint for the antistreptolysin O (ASO) latex agglutination assay? A. Highest serum dilution that shows no agglutination B. Highest serum dilution that shows agglutination C. Lowest serum dilution that shows agglutination D. Lowest serum dilution that shows no agglutination

    B. Highest serum dilution that shows agglutination

  • 22

    Which test, other than serological markers, is most consistently elevated in viral hepatitis? A. Antinuclear antibodies B. Alanine aminotransferase (ALT) C. Absolute lymphocyte count D. Lactate dehydrogenase

    B. Alanine aminotransferase (ALT)

  • 23

    Which of the following was a surrogate test for hepatitis that is no longer required? A. ALT B. Anti-HBc C. CMV D. HBsAg

    A. ALT

  • 24

    The first serologic marker to appear in patients with acute hepatitis B virus infection is A. Anti-HBs B. Anti-HBc C. Anti-HBe D. HBsAg

    D. HBsAg

  • 25

    Which hepatitis B marker is the best indicator of early acute infection? A. HBsAg B. HBeAg C. Anti-HBc D. Anti-HBs

    A. HBsAg

  • 26

    Which surface marker is a reliable marker for the presence of high levels of hepatitis B virus (HBV) and a high degree of infectivity? A. HBe Ag B. HBs Ag C. HBc Ag D. Anti-HBsAg

    A. HBe Ag

  • 27

    Which is the first antibody detected in serum after infection with hepatitis B virus (HBV)? A. Anti-HBs B. Anti-HBc IgM C. Anti-HBe D. All are detectable at the same time

    B. Anti-HBc IgM

  • 28

    Which antibody persists in low-level carriers of hepatitis B virus? A. IgM anti-HBc B. IgG anti-HBc C. IgM anti-HBe D. IgG anti-HBs

    B. IgG anti-HBc

  • 29

    What assay would confirm the immune status of the hepatitis B virus? A. HBsAg B. Anti-HBs C. IgM anti-HBcAg D. Hepatitis C Ag

    B. Anti-HBs

  • 30

    A hospital employee received the final dose of the hepatitis B vaccine 3 weeks ago. She wants to donate blood. Which of the following results are expected from the hepatitis screen, and will she be allowed to donate blood? A. HBsAg, positive; anti-HBc, negative; she may donate B. HBsAg, negative; anti-HBc, positive; she may not donate C. HBsAg, positive; anti-HBc, positive; she may not donate D. HBsAg, negative; anti-HBc, negative; she may donate

    D. HBsAg, negative; anti-HBc, negative; she may donate

  • 31

    If only anti-HBs is positive, which of the following can be ruled out? A. Hepatitis B virus vaccination B. Distant past infection with hepatitis B virus C. Hepatitis B immune globulin (HBIG) injection D. Chronic hepatitis B virus infection

    D. Chronic hepatitis B virus infection

  • 32

    What is the main difficulty associated with the development of an HIV vaccine? A. The virus has been difficult to culture; antigen extraction and concentration are extremely laborious B. Human trials cannot be performed C. Different strains of the virus are genetically diverse D. Anti-idiotype antibodies cannot be developed

    B. Human trials cannot be performed

  • 33

    Tests to identify infection with HIV fall into which three general classification types of tests? A. Tissue culture, antigen, and antibody tests B. Tests for antigens, antibodies, and nucleic acid C. DNA probe, DNA amplification, and Western blot tests D. ELISA, Western blot, and Southern blot tests

    B. Tests for antigens, antibodies, and nucleic acid

  • 34

    What is the advantage of 4th-generation rapid HIV tests over earlier rapid HIV tests? A. They use recombinant antigens B. They detect multiple strains of HIV C. They detect p24 antigen D. D. They are quantitative

    C. They detect p24 antigen

  • 35

    Antibodies to which of the following viral antigens are usually the first to be detected in HIV infection? A. gp120 B. gp160 C. gp41 D. p24

    D. p24

  • 36

    Which of the following combinations of bands would represent a positive Western blot for HIV antibody? A. p24 and p55 B. p24 and p31 C. gp41 and gp120 D. p31 and p55

    C. gp41 and gp120

  • 37

    Interpret the following results for HIV infection. § ELISA: positive § Repeat ELISA: negative § Western blot: no bands A. Positive for HIV B. Negative for HIV C. Indeterminate D. Further testing needed

    B. Negative for HIV

  • 38

    A woman who has had five pregnancies subsequently tests positive for HIV by Western blot. What is the most likely reason for this result? A. Possible cross-reaction with herpes or EBV antibodies B. Interference from medication C. Cross-reaction with HLA antigens in the antigen preparation D. Possible technical error

    C. Cross-reaction with HLA antigens in the antigen preparation

  • 39

    Which of the following tests is CURRENTLY RECOMMENDED BY THE CDC to confirm a positive screening test result for HIV infection? A. Rapid test for HIV-1 and HIV-2 antibodies B. Western blot C. Molecular testing for HIV RNA D. HIV viral culture

    A. Rapid test for HIV-1 and HIV-2 antibodies

  • 40

    Which method is used to test for HIV infection in infants who are born to HIV-positive mothers? A. ELISA B. Western blot test C. Polymerase chain reaction D. Viral culture

    C. Polymerase chain reaction

  • 41

    A newborn is to be tested for a vertically transmitted HIV infection. Which of the following tests is most useful? A. HIV PCR B. CD4 count C. Rapid HIV antibody test D. HIV IgM antibody test

    A. HIV PCR

  • 42

    In monitoring an HIV-infected patient, which parameter may be expected to be the most sensitive indicator of the effectiveness of antiretroviral treatment? A. HIV antibody titer B. CD4:CD8 ratio C. HIV viral load D. Absolute total T-cell count

    C. HIV viral load

  • 43

    HTLV-I and HTLV-II can be transmitted by: A. Bloodborne (transfusion, IV drug abuse) B. Sexual contact (commonly from men to women) C. Mother-to-child (mainly through breastfeeding) D. All of these

    D. All of these

  • 44

    Individuals exposed to EBV maintain an asymptomatic latent infection in: A. B cells B. T cells C. All lymphocytes D. Monocytes

    B. T cells

  • 45

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 46

    Two cross-reacting antigen types of herpes simplex virus have been identified: A. EBV and CMV B. HHV6 and HHV7 C. VZV and CMV D. HSV1 and HSV2

    D. HSV1 and HSV2

  • 47

    Cross-reactions in the complement fixation test for Histoplasma capsulatum occur in patients with ____; but titers appear to be lower. A. Aspergillosis B. Blastomycosis C. Aspergillosis, blastomycosis D. Blastomycosis, aspergillosis, coccidiomycosis

    D. Blastomycosis, aspergillosis, coccidiomycosis

  • 48

    Which of the following fungal organisms is best diagnosed by an antibody detection test as opposed to an antibody detection assay? A. Histoplasma B. Cryptococcus C. Candida D. Aspergillus

    B. Cryptococcus

  • 49

    LATEX AGGLUTINATION for cryptococcal _____ is now recommended test for Cryptococcus neoformans. A. Polysaccharide capsule B. Antigen C. Antibody D. Nucleic acids

    B. Antigen

  • 50

    Serological testing provides the most practical and reliable means of confirming a measles diagnosis. Samples collected before ___ may yield false-negative results, and repeat testing on a later sample is recommended in that situation. A. 72 hours B. 5 days C. 6 days D. 9 days

    A. 72 hours

  • 51

    Blood products are tested for which virus before being transfused to newborns? A. EBV B. Human T-lymphotropic virus II (HTLV-II) C. Cytomegalovirus (CMV) D. Hepatitis D virus

    C. Cytomegalovirus (CMV)

  • 52

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 53

    In general, in which of the following situations is the analysis of a tumor marker most useful? A. Testing for recurrence B. Prognosis C. Screening D. Diagnosis

    A. Testing for recurrence

  • 54

    What is the primary clinical utility of measuring CEA? A. Diagnosis of liver cancer B. Diagnosis of colorectal cancer C. Screening for cancers of endodermal origin D. Monitoring for recurrence of cancer

    D. Monitoring for recurrence of cancer

  • 55

    Which type of cancer is associated with the highest level of AFP? A. Hepatoma B. Ovarian cancer C. Testicular cancer D. Breast cancer

    A. Hepatoma

  • 56

    Which tumor marker is associated with cancer of the urinary bladder? A. CA-19-9 B. CA-72-4 C. Nuclear matrix protein D. Cathepsin-D

    C. Nuclear matrix protein

  • 57

    A 55-year-old male with early stage prostate cancer diagnosed by biopsy had his prostate gland removed (simple prostatectomy). His PSA prior to surgery was 10.0 ng/mL. If the surgery was successful in completely removing the tumor cells, what would the PSA result be 1 month after surgery? A. Undetectable B. 1 to 3 ng/mL C. Less than 4 ng/mL D. Less than 10 ng/mL

    A. Undetectable

  • 58

    A patient has a prostate-specific antigen level of 60 ng/mL the day before surgery to remove a localized prostate tumor. One week following surgery, the serum PSA was determined to be 8 ng/mL by the same method. What is the most likely cause of these results? A. Incomplete removal of the malignancy B. Cross reactivity of the antibody with another tumor antigen C. Testing too soon after surgery D. Hook effect with the PSA assay

    C. Testing too soon after surgery

  • 59

    Which of the following statements regarding the Philadelphia chromosome is true? A. It is seen exclusively in chronic myelogenous leukemia B. It results from a translocation C. It appears as a short-arm deletion of chromosome 21 D. It is associated with a poor prognosis

    B. It results from a translocation

  • 60

    A major advantage of POCT is: A. Faster turnaround time B. Lower cost C. Better quality than traditional testing D. Both A and C

    A. Faster turnaround time

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    What is the lowest level of hormone for which most current serum hCG tests can give a positive result? A. 25 mIU/mL B. 50 mIU/mL C. 100 mIU/mL D. 200 mIU/mL

    A. 25 mIU/mL

  • 2

    In the card pregnancy test, if the test band appears very faint, it is recommended that it is: A. Reported as positive B. Reported as negative C. Test is considered invalid D. New sample collected 48 hours later and tested

    D. New sample collected 48 hours later and tested

  • 3

    Direct examination of the treponemes: A. Light microscopy B. Darkfield microscopy C. VDRL testing D. RPR testing

    B. Darkfield microscopy

  • 4

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? A. Antibodies against syphilis are undetectable B. Detected 1 to 3 weeks after appearance of the primary chancre C. Detected in 50% of cases before the primary chancre disappears D. Detected within 2 weeks after infection

    B. Detected 1 to 3 weeks after appearance of the primary chancre

  • 5

    What substance is detected by the rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests for syphilis? A. Cardiolipin B. Anticardiolipin antibody C. Anti-T. pallidum antibody D. Treponema pallidum

    B. Anticardiolipin antibody

  • 6

    What type of antigen is used in the RPR card test? A. Live treponemal organisms B. Killed suspension of treponemal organisms C. Cardiolipin D. Tanned sheep cells

    C. Cardiolipin

  • 7

    Speed and time of rotation for serum VDRL test: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    C. 180 rpm for 4 minutes

  • 8

    Speed and time of rotation for CSF VDRL test: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    D. 180 rpm for 8 minutes

  • 9

    Speed and time of rotation for RPR: A. 100 rpm for 4 minutes B. 100 rpm for 8 minutes C. 180 rpm for 4 minutes D. 180 rpm for 8 minutes

    B. 100 rpm for 8 minutes

  • 10

    In the RPR test, what is the gauge of the needle for antigen delivery? A. 16 B. 18 C. 20 D. 21

    C. 20

  • 11

    A widely used HEMAGGLUTINATION test for detecting antibody to Treponema pallidum is: A. MHA-TP test B. FTA-ABS test C. VDRL test D. TPI test

    A. MHA-TP test

  • 12

    . Which test is recommended for testing cerebrospinal fluid for detection of neurosyphilis? A. RPR B. VDRL C. FTA-ABS D. Enzyme immunoassay

    B. VDRL

  • 13

    Which specimen is the sample of choice to evaluate latent or tertiary syphilis? A. Serum sample B. Chancre fluid C. CSF D. Joint fluid

    C. CSF

  • 14

    Which test is most likely to be positive in the tertiary stage of syphilis? A. FTA-ABS B. RPR C. VDRL D. Reagin screen test (RST)

    A. FTA-ABS

  • 15

    A biological false-positive reaction is least likely with which test for syphilis? A. VDRL B. FTA-ABS C. RPR D. All are equally likely to detect a false-positive result

    B. FTA-ABS

  • 16

    Which of the following is the most sensitive test to detect congenital syphilis? A. VDRL B. RPR C. Microhemagglutination test for T. pallidum (MHA-TP) D. Polymerase chain reaction (PCR)

    D. Polymerase chain reaction (PCR)

  • 17

    Which control shows the correct result for a valid ASO test? A. SLO control, no hemolysis B. Red cell control, no hemolysis C. Positive control, hemolysis in all tubes D. Hemolysis in both SLO and red cell control

    B. Red cell control, no hemolysis

  • 18

    . Interpret the following ASO results: § Tube Nos. 1–4 (Todd unit 125): no hemolysis § Tube No. 5 (Todd unit 166): hemolysis A. Positive Todd unit 125 B. Positive Todd unit 166 C. No antistreptolysin O present D. Impossible to interpret

    A. Positive Todd unit 125

  • 19

    A single ASO titer is considered to be moderately elevated if the titer is at least _____ Todd units in an adult. A. 200 Todd units B. 240 Todd units C. 320 Todd units D. 340 Todd units

    B. 240 Todd units

  • 20

    A single ASO titer is considered to be moderately elevated if the titer is at least _____ Todd units in a child. A. 200 Todd units B. 240 Todd units C. 320 Todd units D. 340 Todd units

    C. 320 Todd units

  • 21

    What is the endpoint for the antistreptolysin O (ASO) latex agglutination assay? A. Highest serum dilution that shows no agglutination B. Highest serum dilution that shows agglutination C. Lowest serum dilution that shows agglutination D. Lowest serum dilution that shows no agglutination

    B. Highest serum dilution that shows agglutination

  • 22

    Which test, other than serological markers, is most consistently elevated in viral hepatitis? A. Antinuclear antibodies B. Alanine aminotransferase (ALT) C. Absolute lymphocyte count D. Lactate dehydrogenase

    B. Alanine aminotransferase (ALT)

  • 23

    Which of the following was a surrogate test for hepatitis that is no longer required? A. ALT B. Anti-HBc C. CMV D. HBsAg

    A. ALT

  • 24

    The first serologic marker to appear in patients with acute hepatitis B virus infection is A. Anti-HBs B. Anti-HBc C. Anti-HBe D. HBsAg

    D. HBsAg

  • 25

    Which hepatitis B marker is the best indicator of early acute infection? A. HBsAg B. HBeAg C. Anti-HBc D. Anti-HBs

    A. HBsAg

  • 26

    Which surface marker is a reliable marker for the presence of high levels of hepatitis B virus (HBV) and a high degree of infectivity? A. HBe Ag B. HBs Ag C. HBc Ag D. Anti-HBsAg

    A. HBe Ag

  • 27

    Which is the first antibody detected in serum after infection with hepatitis B virus (HBV)? A. Anti-HBs B. Anti-HBc IgM C. Anti-HBe D. All are detectable at the same time

    B. Anti-HBc IgM

  • 28

    Which antibody persists in low-level carriers of hepatitis B virus? A. IgM anti-HBc B. IgG anti-HBc C. IgM anti-HBe D. IgG anti-HBs

    B. IgG anti-HBc

  • 29

    What assay would confirm the immune status of the hepatitis B virus? A. HBsAg B. Anti-HBs C. IgM anti-HBcAg D. Hepatitis C Ag

    B. Anti-HBs

  • 30

    A hospital employee received the final dose of the hepatitis B vaccine 3 weeks ago. She wants to donate blood. Which of the following results are expected from the hepatitis screen, and will she be allowed to donate blood? A. HBsAg, positive; anti-HBc, negative; she may donate B. HBsAg, negative; anti-HBc, positive; she may not donate C. HBsAg, positive; anti-HBc, positive; she may not donate D. HBsAg, negative; anti-HBc, negative; she may donate

    D. HBsAg, negative; anti-HBc, negative; she may donate

  • 31

    If only anti-HBs is positive, which of the following can be ruled out? A. Hepatitis B virus vaccination B. Distant past infection with hepatitis B virus C. Hepatitis B immune globulin (HBIG) injection D. Chronic hepatitis B virus infection

    D. Chronic hepatitis B virus infection

  • 32

    What is the main difficulty associated with the development of an HIV vaccine? A. The virus has been difficult to culture; antigen extraction and concentration are extremely laborious B. Human trials cannot be performed C. Different strains of the virus are genetically diverse D. Anti-idiotype antibodies cannot be developed

    B. Human trials cannot be performed

  • 33

    Tests to identify infection with HIV fall into which three general classification types of tests? A. Tissue culture, antigen, and antibody tests B. Tests for antigens, antibodies, and nucleic acid C. DNA probe, DNA amplification, and Western blot tests D. ELISA, Western blot, and Southern blot tests

    B. Tests for antigens, antibodies, and nucleic acid

  • 34

    What is the advantage of 4th-generation rapid HIV tests over earlier rapid HIV tests? A. They use recombinant antigens B. They detect multiple strains of HIV C. They detect p24 antigen D. D. They are quantitative

    C. They detect p24 antigen

  • 35

    Antibodies to which of the following viral antigens are usually the first to be detected in HIV infection? A. gp120 B. gp160 C. gp41 D. p24

    D. p24

  • 36

    Which of the following combinations of bands would represent a positive Western blot for HIV antibody? A. p24 and p55 B. p24 and p31 C. gp41 and gp120 D. p31 and p55

    C. gp41 and gp120

  • 37

    Interpret the following results for HIV infection. § ELISA: positive § Repeat ELISA: negative § Western blot: no bands A. Positive for HIV B. Negative for HIV C. Indeterminate D. Further testing needed

    B. Negative for HIV

  • 38

    A woman who has had five pregnancies subsequently tests positive for HIV by Western blot. What is the most likely reason for this result? A. Possible cross-reaction with herpes or EBV antibodies B. Interference from medication C. Cross-reaction with HLA antigens in the antigen preparation D. Possible technical error

    C. Cross-reaction with HLA antigens in the antigen preparation

  • 39

    Which of the following tests is CURRENTLY RECOMMENDED BY THE CDC to confirm a positive screening test result for HIV infection? A. Rapid test for HIV-1 and HIV-2 antibodies B. Western blot C. Molecular testing for HIV RNA D. HIV viral culture

    A. Rapid test for HIV-1 and HIV-2 antibodies

  • 40

    Which method is used to test for HIV infection in infants who are born to HIV-positive mothers? A. ELISA B. Western blot test C. Polymerase chain reaction D. Viral culture

    C. Polymerase chain reaction

  • 41

    A newborn is to be tested for a vertically transmitted HIV infection. Which of the following tests is most useful? A. HIV PCR B. CD4 count C. Rapid HIV antibody test D. HIV IgM antibody test

    A. HIV PCR

  • 42

    In monitoring an HIV-infected patient, which parameter may be expected to be the most sensitive indicator of the effectiveness of antiretroviral treatment? A. HIV antibody titer B. CD4:CD8 ratio C. HIV viral load D. Absolute total T-cell count

    C. HIV viral load

  • 43

    HTLV-I and HTLV-II can be transmitted by: A. Bloodborne (transfusion, IV drug abuse) B. Sexual contact (commonly from men to women) C. Mother-to-child (mainly through breastfeeding) D. All of these

    D. All of these

  • 44

    Individuals exposed to EBV maintain an asymptomatic latent infection in: A. B cells B. T cells C. All lymphocytes D. Monocytes

    B. T cells

  • 45

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 46

    Two cross-reacting antigen types of herpes simplex virus have been identified: A. EBV and CMV B. HHV6 and HHV7 C. VZV and CMV D. HSV1 and HSV2

    D. HSV1 and HSV2

  • 47

    Cross-reactions in the complement fixation test for Histoplasma capsulatum occur in patients with ____; but titers appear to be lower. A. Aspergillosis B. Blastomycosis C. Aspergillosis, blastomycosis D. Blastomycosis, aspergillosis, coccidiomycosis

    D. Blastomycosis, aspergillosis, coccidiomycosis

  • 48

    Which of the following fungal organisms is best diagnosed by an antibody detection test as opposed to an antibody detection assay? A. Histoplasma B. Cryptococcus C. Candida D. Aspergillus

    B. Cryptococcus

  • 49

    LATEX AGGLUTINATION for cryptococcal _____ is now recommended test for Cryptococcus neoformans. A. Polysaccharide capsule B. Antigen C. Antibody D. Nucleic acids

    B. Antigen

  • 50

    Serological testing provides the most practical and reliable means of confirming a measles diagnosis. Samples collected before ___ may yield false-negative results, and repeat testing on a later sample is recommended in that situation. A. 72 hours B. 5 days C. 6 days D. 9 days

    A. 72 hours

  • 51

    Blood products are tested for which virus before being transfused to newborns? A. EBV B. Human T-lymphotropic virus II (HTLV-II) C. Cytomegalovirus (CMV) D. Hepatitis D virus

    C. Cytomegalovirus (CMV)

  • 52

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 53

    In general, in which of the following situations is the analysis of a tumor marker most useful? A. Testing for recurrence B. Prognosis C. Screening D. Diagnosis

    A. Testing for recurrence

  • 54

    What is the primary clinical utility of measuring CEA? A. Diagnosis of liver cancer B. Diagnosis of colorectal cancer C. Screening for cancers of endodermal origin D. Monitoring for recurrence of cancer

    D. Monitoring for recurrence of cancer

  • 55

    Which type of cancer is associated with the highest level of AFP? A. Hepatoma B. Ovarian cancer C. Testicular cancer D. Breast cancer

    A. Hepatoma

  • 56

    Which tumor marker is associated with cancer of the urinary bladder? A. CA-19-9 B. CA-72-4 C. Nuclear matrix protein D. Cathepsin-D

    C. Nuclear matrix protein

  • 57

    A 55-year-old male with early stage prostate cancer diagnosed by biopsy had his prostate gland removed (simple prostatectomy). His PSA prior to surgery was 10.0 ng/mL. If the surgery was successful in completely removing the tumor cells, what would the PSA result be 1 month after surgery? A. Undetectable B. 1 to 3 ng/mL C. Less than 4 ng/mL D. Less than 10 ng/mL

    A. Undetectable

  • 58

    A patient has a prostate-specific antigen level of 60 ng/mL the day before surgery to remove a localized prostate tumor. One week following surgery, the serum PSA was determined to be 8 ng/mL by the same method. What is the most likely cause of these results? A. Incomplete removal of the malignancy B. Cross reactivity of the antibody with another tumor antigen C. Testing too soon after surgery D. Hook effect with the PSA assay

    C. Testing too soon after surgery

  • 59

    Which of the following statements regarding the Philadelphia chromosome is true? A. It is seen exclusively in chronic myelogenous leukemia B. It results from a translocation C. It appears as a short-arm deletion of chromosome 21 D. It is associated with a poor prognosis

    B. It results from a translocation

  • 60

    A major advantage of POCT is: A. Faster turnaround time B. Lower cost C. Better quality than traditional testing D. Both A and C

    A. Faster turnaround time